Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.
Moroni G, Depetri F, Del Vecchio L, Gallelli B, Raffiotta F, Giglio E, Brunini F, D'Amico M, Longhi S, Radice A, Messa P, Sinico RA.
Moroni G, et al.
Nephrol Dial Transplant. 2017 Oct 1;32(10):1691-1696. doi: 10.1093/ndt/gfw251.
Nephrol Dial Transplant. 2017.
PMID: 27387472